Modern strategies for the treatment of patients with autosomal dominant polycystic kidney disease
- Authors: Trushkin R.N.1, Medvedev P.E.1, Isaev T.K.1, Klementieva T.M.1, Morozov N.V.1, Ivanov K.V.2
-
Affiliations:
- City Clinical Hospital № 52 of the Moscow Healthcare Department
- Moscow Multidisciplinary Clinical Center "Kommunarka" of the Moscow Healthcare Department
- Issue: Vol 14, No 4 (2022)
- Pages: 33-42
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/275473
- DOI: https://doi.org/10.18565/nephrology.2022.4.33-42
- ID: 275473
Cite item
Abstract
Full Text
About the authors
Ruslan N. Trushkin
City Clinical Hospital № 52 of the Moscow Healthcare Department
Email: uro52@mail.ru
Dr.Sci. (Med.), Head of the Department of Urology Moscow, Russia
Pavel E. Medvedev
City Clinical Hospital № 52 of the Moscow Healthcare Department
Email: pah95@mail.ru
Urologist, Urology Department Moscow, Russia
Teymur K. Isaev
City Clinical Hospital № 52 of the Moscow Healthcare Department
Email: dr.isaev@mail.ru
Cand. Sci. (Med.), Urologist, Urology Department Moscow, Russia
Tamara M. Klementieva
City Clinical Hospital № 52 of the Moscow Healthcare Department
Email: tamara-klementeva@mail.ru
Nephrologist Moscow, Russia
Nikolay V. Morozov
City Clinical Hospital № 52 of the Moscow Healthcare Department
Email: nikmorozov@rambler.ru
Urologist, Urology Department Moscow, Russia
Konstantin V. Ivanov
Moscow Multidisciplinary Clinical Center "Kommunarka" of the Moscow Healthcare DepartmentUrologist, Urology Department Moscow, Russia
References
- Bikbov B., Purcell C.A., Levey Global A.S., regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet. 2020;395(10225):709-33. doi: 10.1016/S0140-6736(20)30045-3. [Epub 2020 Feb 13].
- Kerr M., Bray B., Medcalf J. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol. Dial. Transplant. 2012;27(Suppl. 3): iii73-80. doi: 10.1093/ndt/gfs269. [Epub 2012 Aug 5].
- Мыльников М. «VADEMECUM»., разд. Мединдустрия. («Нефро-Лига» предложила Правительству РФ проиндексировать тарифы на диализ на 40-70%). 24.03.2022. https://vademec.ru/news/2022/03/24/nefro-liga-predlozhila-pravitelstvu-rf-proindeksirovat-tarify-na-dializ-na-40-70. @@Mylnikov M. "VADEMECUM", sec. Medical industry. (Nefro-Liga proposed to the Government of the Russian Federation to index tariffs for dialysis by 40-70%). 03/24/2022.
- U.S. Renal Data System: USRDS 2014 Annual Data Report, 2014.
- Grantham J.J., Torres V.E., Chapman A.B., et al. CRISP Investigators. Volume progression in polycystic kidney disease. N. Engl. J. Med. 2006; 354(20):2122-30. Doi.org/10.1056/NEJMoa054341 PMID: 16707749.
- Echevers Y.M., Toapanta N., Perez N.N. Survival of patients >70 years with advanced chronic kidney disease: Dialysis vs. conservative care. Nefrologia: publicacion oficial de la Sociedad Esp. Nefrol 2016;36(3). doi: 10.1016/j.nefro.2015.11.006.
- Helal I. Autosomal dominant polycystic kidney disease: new insights into treatment. Saudi J. Kidney Dis. Transpl. 2013;24(2):230-34. Doi. org/10.4103/1319-2442.109561 PMID: 23538343.
- Binsaleh S., et. al.Comparison of laparoscopic and open nephrectomy for adult polycystic kidney disease: operative challenges and technique. Canad. J. Urol. 2006;6(13):3340-45.
- Rim H., Jung G.S., Jung Y.S. Transcatheter arterial embolization using ethanol in a dialysis patient for contracting enlarged polycystic kidneys. Korean J. Radiol. 2010;11:574-78. doi: 10.3348/kjr.2010.11.5.574.
- ВОЗ: https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death 09.12.2020. WHO https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death 09.12.2020.
- Хроническая болезнь почек (ХБП). Клинические рекомендации Минздрава России. 2021. (Электронный ресурс.) URL: https://www.rusnephrology.org/wp-content/uploads/2020/12/CKD_Jinal.pdf (дата обращения: 07.04.2022). @@Chronic kidney disease (CKD). Clinical recommendations of the Ministry of Health of the Russian Federation. 2021. (Electronic resource.) URL: https://www.rusnephrology.org/wp-content/uploads/2020/12/CKD_final.pdf (access date: 07.04.2022) (in Russ.)
- Андрусев А.М., Томилина Н.А., Перегудова Н.Г., Шинкарев М.Б. Заместительная почечная терапия хронической болезни почек 5-й стадии в Российской Федерации 2015-2019 гг. Отчет по данным Общероссийского Регистра заместительной почечной терапии Российского диализного общества. Нефрология и диализ. 2021;23(3):255-329. doi: 10.28996/2618-9801-2021-3-255-329. @@Andrusev A.M., Tomilina N.A., Peregudova N.G., Shinkarev M.B. Kidney replacement therapy for end Stage Kidney Disease in Russian Federation, 2015-2019.Russian National Kidney Replacement Therapy Registry Report of Russian Public Organization of Nephrologists “Russian Dialysis Society”. Nephrol. Dial. 2021;23(3):255-329. doi: 10.28996/2618-9801-2021-3-255-329.
- Чугунова О.Л., Черкасова С.В., Туманова Е.Л. Поликистозная болезнь почек у новорожденных и детей раннего возраста: проблемы диагностики, ведения и лечения. Педиатрия. 2015;94(3):88-94. @@Chugunova O.L., Cherkasova S.V, Tumanova E.L. Polycystic kidney disease in newborns and young children: problems of diagnosis, management and treatment. Pediatr. 2015;94(3):88-94.
- Balat A. Tear drops of kidney: a historical overview of Polycystic Kidney Disease. J. Ital. Nefrol. 2016;33(Suppl. 66):33.S66.21. PMID: 26913889.
- Steiner P. Ueber grosscystische Degeneration der Nieren und der Leber. Deutsche Med. Wocheschr. 1899;25:677-78.
- Reed B., McFann K, Kimberling W.J., et al. Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history. Am. J. Kidney Dis.: Official J. National Kidney Foundat. 2008;52(6):1042-50. https://doi.org/10.1053/j.ajkd.2008.05.015
- Porath B, Gainullin V.G., Cornec-Le Gall E., et al. Mutations in GANAB, encoding the glucosidase II alpha subunit, cause autosomal-dominant polycystic kidney and liver disease. Am. J. Human. Genet. 2016;98(6):1193-207. doi: 10.1016/j.ajhg.2016.05.004.
- Ars E., Bernis C., Fraga G. Spanish guidelinesfor the management of autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 2014; 29(Suppl. 4):iv95-105. doi: 10.1093/ndt/gfu186.
- Руденко Т.Е., Бобкова И.Н., Ставровская Е.В. Современные подходы к консервативной терапии поликистозной болезни почек. Тер. архив. 2019;91(6):116-23. doi: 10.26442/00403660.2019.06.000299. @@Rudenko T.E., Bobkova I.N., Stavrovskaya E.V. Modern approaches to conservative therapy of polycystic kidney disease. Ther. Arch. 2019;91(6):116-23.
- Reiterova J.; Tesar V. Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment.Int. J. Mol. Sci. 2022;23:3317. https://doi.org/10.3390/ijms23063317
- Волынец Л. И., Нарезкин Д. В., Толкачев А. Н. Поликистоз почек: современное состояние проблемы. Вестник Смоленской государственной медицинской академии. Клин. медицина. УДК: 616.61-006.31. @@Volynets L.I., Narezkin D.V., Tolkachev A.N. Polycystic kidney: modern aspects of the problem. Bull. Smolensk State Med. Acad. Clin. Med. UDC: 616.61-006.31].
- Horie S., Mochizuki T., Muto S., et al. Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clin. Exp. Nephrol. 2016;20(4):493-509. https://doi.org/10.1007/s10157-015-1219-7
- Grantham J.J., Chapman A.B., Torres V.E: Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes. Clin. J. Am. Soc. Nephrol. 2006;1:148-57.
- Chapman A.B., Bost J.E., Torres V.E., et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol 2012;7:479-86.
- Hayne Cho Park, Yeji Hong, Jeong-Heum Yeon, et al. Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study. Kidney Res. Clin. Pract. 2022;41(4):432-41. Published online: March 3, 2022. Doi: https://doi.org/10.23876/j.krcp.21.261.
- Rosenberg S., Virmani S., Klarman Sh., et al. Mayo Imaging Classification May Be Useful in Determining the Need for Nephrectomy in ADPKD. Kidney360 February. 2021;2(2):325-30. Doi: https://doi.org/10.34067/KID.0003902020.
- Irazabal M.V., Rangel L.J. Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials. JASN. 2015;26(1):160-72. Doi: https://doi.org/10.1681/ASN.2013101138.
- Tangri N., Hougen I., Alam A. Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Can. J. Kidney Health Dis. 2017;4:2054358117693355. doi: 10.1177/2054358117693355. eCollection 2017.
- Jones B.E., Mkhaimer Y.G., Rangel L.J. Asymptomatic Pyuria as a Prognostic Biomarker in Autosomal Dominant Polycystic Kidney Disease. Kidney 360. 2022;3:465-76. Doi: https://doi.org/10.34067/KID.0004292021.
- Torres V.E., Abebe K., Chapman, et al. Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease. N. Engl. J. Med. 2014;371:2267-76.
- Супрунович К.С. Аутосомно-доминантная поликистозная болезнь почек: [Электронныйресурс]. Генокарта Генетическая энциклопедия. 2022. URL: https://www.genokarta.ru/disease/Autosomnodominantnaya_polikistoznaya_bolezn_pochek @@Suprunovich K.S. Autosomal dominant polycystic kidney disease: [Electronic resource]. Genocarda Genetic Encyclopedia. 2022. URL: http://www.genokarta.ru/disease/Autosomnodominantnaya_polikistoznaya_bolezn_pochek
- Woodhead J.L., Pellegrini L., Shoda L.K.M., Howell B.A.Comparison of the Hepatotoxic Potential of Two Treatments for Autosomal-Dominant Polycystic Kidney Disease Using Quantitative Systems Toxicology Modeling. Pharm. Res. 2020;37(2):24. doi: 10.1007/s11095-019-2726-0.
- Meijer E., Drenth J.P., dAgnolo, et al. Rationale and design of the DIPAK 1 study: A randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 2014;63(3):446-55. doi: 10.1053/j.ajkd.2013.10.011. [Epub 2013 Dec 15].
- Serra A.L., Poster D., Kistler A.D., et al. Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease. N. Engl. J. Med. 2010;363(9):820-9. doi: 10.1056/NEJMoa0907419. [Epub 2010 Jun 26].
- The National Library of Medicine (NLM). Clinical Trials.gov. https://clinicaltrials.gov.
- Perrone R.D., Abebe K.Z., Watnick T.J., et al. Primary results of the randomized trial of metformin administration in polycystic kideny disease (TAME PKD). Kidney Int. 2021;100(3):684-96. doi: 10.1016/j.kint.2021.06.013. [Epub 2021 Jun 27].
- Chediak A.E., Degheili J.A., Khauli R.B. Genitourinary Interventions in Autosomal Dominant Polycystic Kidney Disease: Clinical Recommendations for Urologic and Transplant Surgeons. Exp. Clin. Transplant. 2021;19(2):95-103. doi: 10.6002/ect.2020.0292. [Epub 2021 Jan 26].
- Comelis F., Couzi L., Le Bras Y., et al. Embolization of polycystic kidneys as an alternative to nephrectomy before renal transplantation: a pilot study. Am. J. Transplant. 2010;10(10):2363- 69. http://dx.doi.org/10.1111/j.1600-6143.2010.03251.x PMID: 21143393.
- Sallee VI., Rafat C., Zahar J.R., et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol 2009; 4(7): 1183-89. http://dx.doi.org/10.2215/ CJN.01870309 [PMID: 19470662 PMCid:PMC2709515].
- Lahiri S.A., Halff G.A., Speeg K.V., Esterl R.M. In-111 WBC scan localizes infected hepatic cysts and confirms their complete resection in adult polycystic kidney disease. Clin. Nucl. Med. 1998;23(l):33-4. http://dx.doi.org/10.1097/00003072-199801000-00010 PMID: 9442963
- Ishikawa I., Saito Y., Asaka V.I., et al. Twenty-yearfollow-up of acquired renal cystic disease. Clin. Nephrol. 2003;59(3):153-9. http://dx.doi.org/10.5414/ CNP59153 PMID: 12653256
- Лубенников А.Е., Нефрэктомия у больных с терминальной стадией хронической почечной недостаточности. Дисс. док. мед. наук. М., 2021. @@Lubennikov A.E., Nephrectomy in patients with end-stage chronic renal failure: author. Diss. MD. M., 2021].
- Amesur P., Castronuovo J.J., Chandramouly B. Infected cyst localization with gallium SPECT imaging in polycystic kidney disease. Clin. Nucl. Med. 1988; 13(l):35- 7. http://dx.doi.org/10.1097/00003072-198801000-00010 PMID: 3258216
- Dang J., Knebelmann B., Charlier C. FC 010 4-Week Antibiotic Therapy Prevents Recurrent Renal Cyst Infections in Autosomal Dominant Polycystic Kidney Disease. Nephrol. Dial. Transplant. 2021;36(Suppl. 1). doi: 10.1093/ndt/gfab125.003.
- Suwabe T. Cyst infection in autosomal dominant polycystic kidney disease: our experience at Toranomon Hospital and future issues. Clin. Exp. Nephrol. 2020;24:748-61. https://doi.org/10.1007/s10157-020-01928-2
- Kazimirov V.G., Butrin S.V., Sapozhnikov A.D. Kidney transplantation inpatients with autosomal dominant polycystic kidney disease. Volgograd: Gosudarstvennoye uchrezhdeniye «Izdatel'», 2003. 112 p.Russian (Казимиров В.Г., Бутрин С.В., Сапожников А.Д. Трансплантация почки у больных с ауто-сомно-доминантным поликистозом почек. Волгоград: Государственное учреждение «Издатель», 2003. 112 с.).
- Veroux M. и др. Change in kidney volume after kidney transplantation in patients with autosomal polycystic kidney disease. PloS one. 2018;12(13):e0209332.
- Bennett A.H., Lazarus J.M. Bilateral nephrectomy performed on an emergency basis for life-threatening malignant hypertension. Surg. Gynecol. Obstet. 1973;137(3): 451-52. [PMID: 4721516].
- Martin A.D., Mekeel K.L., Castle E.P., et al. Laparoscopic bilateral native nephrectomies with simultaneous kidney transplantation. BJU.Int. 2012;110(11 Pt. C):E1003-7. 22882539]' target='_blank'>http://dx.doi.Org/10.llll/j.1464-410X.2012.11379.x.[PMID: 22882539]
- Kirkman M.A., van Dellen D., Mehra S., et al. Native nephrectomy for autosomal dominant polycystic kidney disease: before or after kidney transplantation? BJU.Int. 2011;108(4):590-94. http://dx.doi.Org/10.llll/j.1464-410X.2010.09938.x PMID: 21166760
- Argyrou C., Moris D., Vernadakis S. Tailoring the ‘perfect fit’ for renal transplant recipients with end-stage polycystic kidney disease: Indications and timing of native nephrectomy. In Vivo 31:307-312, 2017. https://doi.org/10.21873/invivo.11060
- Brazda E., Ofner D., Riedmann B., et al. The effect of nephrectomy on the outcome of renal transplantation in patients with polycystic kidney disease. Ann. Transplant. 1996;l(2):15-8 [PMID: 9869924].
- Elashry O.M., Nakada S.Y., Wolf J.S., et al. Laparoscopy for adult polycystic kidney disease: a promising alternative. Am. J. Kidney Dis. 1996;27(2): 224-33. http://dx.doi.org/10.1016/50272-6386(96)90545-4
- Jenkins M.A., Crane J.J., Munch L.C. Bilateral hand-assisted laparoscopic nephrectomy for autosomal dominant polycystic kidney disease using a single midline HandPort incision. J. Urol. 2002;59(l):32-6. http://dx.doi.org/10.1016/50090-4295(01)01461-3
- Gill I.S., Kaouk J.H., Hobart M.G., et al. Laparoscopic bilateral synchronous nephrectomy for autosomal dominant polycystic kidney disease: the initial experience. J. Urol. 2001;165(4):1093-98. http://dx.doi.org/10.1016/S0022-5347(05)66435-X
- Lipke M.C., Bargman V., Milgrom M., Sundaram C.P. Limitations of laparoscopy for bilateral nephrectomy for autosomal dominant polycystic kidney disease. J. Urol. 2007;177(2):627-31. http://dx.doi.org/10.1016/j.juro.2006.09.026 PMID: 17222647
- Whitten M.G., Van Der W.W., Belnap L. A novel approach to bilateralhand-assisted laparoscopic nephrectomy for autosomal dominant polycystic kidneydisease. Surg. Endoscop. Other Interv. Techniq. 2006;4(20):679-84.
- Neeff H.P., Pisarski P., Tittelbach-Helmrich D., et al. One hundred consecutive kidney transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 2013;28(2):466-71. 23042709' target='_blank'>http://dx.doi.org/10.1093/ndt/gfsll8PMID: 23042709
- Sulikowski T., Tejchman K., Zietek Z., et al. Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation. Transplant. Proc. 2009;41(l):177-80. http://dx.doi.org/10.1016/j.transproceed.2008.10.034 PMID: 19249508
- Mendez R., Mendez R.G., Payne J.E., Berne T.V. Renal transplantation. In adult patients with end stage polycystic kidney disease. J. Urol. 1975;5(l):26-7. http://dx.doi.org/10.1016/0090-4295(75)90295-2
- Kramer A., Sausville J., Haririan A., et al. Simultaneous bilateral native nephrectomy and living donor renal transplantation are successful for polycystic kidney disease: the University of Maryland experience. J. Urol. 2009;181(2):724-28. 19091353]' target='_blank'>http://dx.doi.org/10.1016/j.juro.2008.10.008.[PMID: 19091353]
- Tyson M.D., Wisenbaugh E.S., Andrews P.E., et al. Simultaneous kidney transplantation and bilateral native nephrectomy for polycystic kidney disease. J. Urol. 2013;190(6):2170-74. http://dx.doi.org/10.1016/jjuro.2013.05.057 PMID: 23727414
- Tabibi A., Simforoosh N., Abadpour P., et al. Concomitant nephrectomy of massively enlarged kidneys and renal transplantation in autosomal dominant polycystic kidney disease. Transplant. Proc. 2005;37(7):2939-40. 16213267]' target='_blank'>http://dx.doi.org/10.1016/j.transproceed.2005.07.053.[PMID: 16213267]
- Ronsin Ch., Chaba A. , Suchanek O. Incidence, Risk Factors and Outcomes of Kidney and Liver Cyst Infection in Kidney Transplant Recipient With ADPKD. Kidney Int. Rep. 2022;7:867-75. https://doi.org/10.1016/j.ekir.2022.01.1062
- Oguro M., Suwabe T., Ubara Y. Repetitive Refractory Renal Cyst Infection in Autosomal Dominant Polycystic Kidney Disease for which Renal Transcatheter Arterial Embolization Was Effective in Preventing Recurrence.Intern. Med. 2021;60(20):3261-65. doi: 10.2169/internalmedicine.6974-20. [Epub 2021 Oct 15].